Failure to Expand Wholesale and New Sales Channels in the Asia-Pacific Region and Elsewhere
First written in FY2021. 2 of 7 entries say "Worsened", first in FY2022-Q1. Latest entry: 2026-07-14.
Premier Anti-Aging moved to the "Worse" side of this theme in 2021.
0 other companies' latest entry also says "Reframed".
- 2026-07-14ReframedM&A and Subsidiary Changes
「We decided to consolidate our sales structure in China into more efficient and growth-oriented cross-border EC, or overseas flagship stores, and, as part of this, dissolve and liquidate BAM, our local subsidiary.」
The channel policy shifted from expanding sales through a local Chinese subsidiary to consolidating sales through cross-border EC and overseas flagship stores. - FY2025AdvancedAnnual report
「In addition, the company launched the new skincare brand Lalaskin (ララスキン), based on the concept of fast beauty treatments, at selected variety stores, drugstores, GMS retailers and e-commerce marketplaces from April 2025, ahead of a full-scale rollout at approximately 5,000 stores nationwide from September.」
In domestic wholesale and retail channels, Lalaskin progressed from its initial launch to deployment at approximately 5,000 stores nationwide. - FY2023ReframedAnnual report
「The company narrowed the target markets, which had expanded to more than 10 countries through its previous exploration, to countries and regions in Greater China that have strong links to inbound demand in Japan.」
The company announced a strategic shift to narrow its target markets to Greater China in response to the risks surrounding overseas channel expansion. In Japan, the number of wholesale distribution outlets had expanded to approximately 18,000. - FY2023-Q1Progress in domestic wholesale channelsAnnual report
「In line with the television commercials from October, we also expanded into retail stores, completing distribution to 8,000 retail stores by the end of October.」
Expansion of the new brand's domestic retail channels has made concrete progress. However, this filing contains no new update on channel expansion in China or the Asia-Pacific region. - FY2022WorsenedAnnual report
「During the consolidated fiscal year, the company reviewed its overseas strategy, partly due to China's advertising regulations and the impact of lockdowns related to COVID-19.」
Chinese regulations and lockdowns constrained the marketing initiatives underpinning the overseas business plan and channel expansion, leading to a review of the strategy. - FY2022-Q1WorsenedAnnual report
「In the overseas business, regulations imposed by Chinese authorities on the use of talent acted as a brake on the planned marketing initiatives, and we are redrafting our promotional strategy.」
Regulations imposed by the Chinese authorities constrained planned marketing initiatives for the overseas business, worsening the conditions underpinning expansion into new overseas channels. - FY2021First statedAnnual report
「The company is also expanding wholesale sales to drugstores and other outlets to develop a broader customer base, as well as into the Asia-Pacific region, where market expansion is expected. These markets are large, and the company is working to expand sales opportunities. However, if these business activities fail to expand as expected due to rapid changes in the surrounding environment or other factors, they could affect the Group's business and performance.」
The filing newly identifies the risk that expansion of new wholesale and Asia-Pacific channels may fail to grow as expected due to external conditions and other factors.